Stryker Corporation (SYK)

327,45 -8,58 (-2,55%) Alla chiusura: 04:00PM EDT

Stryker Corporation

1941 Stryker Way
Portage, MI 49002
United States
269 385 2600
https://www.stryker.com

Settore/i: Healthcare
Settore: Medical Devices
Impiegati a tempo pieno: 52.000

Figure dirigenziali chiave

Nome	Titolo	Retribuzione	Esercitate	Anno di nascita
Mr. Kevin A. Lobo	Chairman, CEO & President	5,7M	33,71M	1965
Mr. Glenn S. Boehnlein	VP & CFO	2,27M	5,44M	1962
Mr. Viju S. Menon	Group President of Global Quality & Operations	1,68M	N/D	1968
Mr. J. Andrew Pierce	Group President of MedSurg & Neurotechnology	2,03M	2,69M	1974
Mr. Spencer S. Stiles	Group President of Orthopaedics & Spine	2,02M	2,33M	1977
Mr. William E. Berry Jr.	VP & Chief Accounting Officer	N/D	N/D	1966
Mr. Robert C. Cohen	CTO and VP of Global R&D - Joint Replacement	N/D	N/D	N/D
Mr. Alan Douville	VP, Chief Information Officer & Chief Information Security Officer	N/D	N/D	N/D
Mr. Robert S. Fletcher	VP & Chief Legal Officer	895,89k	N/D	1971
Ms. Dana S. McMahon	VP & Chief Compliance Officer	N/D	N/D	N/D

Gli importi risalgono al giorno 31 dicembre 2023 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in USD.

Descrizione

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.

Governance aziendale

L'ISS Governance QualityScore di Stryker Corporation al 1 aprile 2024 è 6. I criteri di valutazione fondamentali sono revisione: 7; Consiglio di Amministrazione: 5; diritti degli azionisti: 6; retribuzione: 5.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.